" Telo Genomics (TSXV:TELO) completes first tranche of private placement

Telo Genomics (TELO) has closed the first tranche of its previously announced non-brokered private placement.

" Cannara Biotech (TSXV:LOVE) acquires TGOD’s cultivation and manufacturing facility

Cannara Biotech has entered into a definitive agreement to acquire a licensed cultivation and manufacturing facility.

" NervGen Pharma (TSXV:NGEN) closes overnight marketed equity offering

NervGen Pharma (NGEN) has closed its previously announced overnight marketed public offering of units.